Legato Capital Management »

Fennec Pharmaceuticals shares owned by Legato Capital Management

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $635k 57k 11.12

More positions owned by Legato Capital Management

Broadcom (AVGO)
Apple (AAPL)
UFP Technologies (UFPT)
Ies Hldgs (IESC)
Microsoft Corporation (MSFT)
Stryker Corporation (SYK)
Accenture (ACN)
ePlus (PLUS)
Bgc Group Inc Cl A (BGC)
Visa (V)
Merck & Co (MRK)
Agilysys (AGYS)
Argan (AGX)
Stonex Group (SNEX)
Alphabet Inc Class A cs (GOOGL)

View all positions for Legato Capital Management

Top funds holding Fennec Pharmaceuticals

Southpoint Capital Advisors
venBio Select Advisor
Vanguard Group
DG Capital Management
AIGH Capital Management
Jeffrey L. Gendell
Essex Investment Management
Worth Venture Partners
683 Capital Management
Lion Point Capital
Legato Capital Management
Susquehanna International
Bank of New York Mellon
Hartford Financial Management
Charles Schwab Investment Management

View all funds holding Fennec Pharmaceuticals